G 1 Care Pharma (India) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-12-2024
- Paid Up Capital ₹ 0.10 M
as on 16-12-2024
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 3174.05%
(FY 2022)
- Profit 107.73%
(FY 2022)
- Ebitda -563.49%
(FY 2022)
- Net Worth 14.41%
(FY 2022)
- Total Assets 937.58%
(FY 2022)
About G 1 Care Pharma (India)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Siddharth Jain and Rama Lawania serve as directors at the Company.
- CIN/LLPIN
U33119RJ2020PTC070704
- Company No.
070704
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Sep 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Kota, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at G 1 Care Pharma (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siddharth Jain  | Director | 01-Sep-2020 | Current |
| Rama Lawania | Director | 25-Oct-2020 | Current |
Financial Performance of G 1 Care Pharma (India).
G 1 Care Pharma (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 3174.05% increase. The company also saw a substantial improvement in profitability, with a 107.73% increase in profit. The company's net worth Soared by an impressive increase of 14.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of G 1 Care Pharma (India)?
Unlock access to G 1 Care Pharma (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Dinkar Power Infra And Logistic Private LimitedActive 4 years 10 months
Siddharth Jain is a mutual person
- Brand Building Business Buddy Private LimitedActive 9 months 25 days
Siddharth Jain is a mutual person
- Shubhsphare Media And Marketing Private LimitedActive 5 months 21 days
Siddharth Jain is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at G 1 Care Pharma (India)?
G 1 Care Pharma (India) has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of G 1 Care Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped G 1 Care Pharma (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.